← The Wire
EOLSNasdaq
Evolus, Inc.
Pharmaceutical Preparations · DE · CIK 1570562
Evolus, Inc. provides breakthrough injectable neurotoxins and hyaluronic acid gels for the cash-pay aesthetic market
$443M
Market cap
$7.13
Last close
0.0%
1D
+8.2%
5D
670K
Volume
Price · last 39 sessions+27.8%
May 4L $5.58 · H $7.15Jun 29
180
Total filings
Jun 12, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 12, 202610-Q10-QMay 4, 20268-KResults of Operations · Reg FD DisclosureMay 4, 2026DEFA14ADEFA14AApr 29, 2026DEF 14ADEF 14AApr 29, 20268-KExecutive ChangeMar 13, 202610-K10-KMar 3, 20268-KMaterial Agreement · Results of OperationsMar 3, 20268-KResults of OperationsJan 9, 202610-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KExecutive Change · Reg FD DisclosureSep 8, 202510-Q10-QAug 5, 20258-KExecutive Change · Results of OperationsAug 5, 20258-KExecutive Change · Shareholder VoteJun 6, 20258-KExecutive Change · Reg FD DisclosureMay 27, 202510-Q10-QMay 7, 20258-KResults of OperationsMay 7, 20258-KMaterial Agreement · New Debt / ObligationMay 5, 2025DEFA14ADEFA14AApr 25, 2025DEF 14ADEF 14AApr 25, 202510-K10-KMar 4, 20258-KResults of OperationsMar 4, 20258-KResults of OperationsJan 21, 202510-Q10-QNov 6, 20248-KResults of OperationsNov 6, 202410-Q10-QJul 31, 20248-KResults of OperationsJul 31, 20248-KExecutive Change · Reg FD DisclosureJul 1, 20248-KExecutive Change · Shareholder VoteJun 11, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 26, 2024DEF 14ADEF 14AApr 26, 20248-KExecutive ChangeApr 3, 20248-KMaterial AgreementMar 13, 2024424B5424B5Mar 11, 202410-K10-KMar 7, 20248-KResults of OperationsMar 7, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GJan 29, 20248-KResults of OperationsJan 16, 20248-KMaterial Agreement · Reg FD DisclosureDec 20, 2023SC 13GSC 13GNov 27, 202310-Q10-QNov 7, 20238-KResults of OperationsNov 7, 202310-Q10-QAug 2, 20238-KResults of OperationsAug 2, 20238-KResults of OperationsJul 27, 2023SC 13GSC 13GJun 16, 20238-KBylaw Amendment · Shareholder VoteJun 14, 2023424B5424B5Jun 9, 202310-Q10-QMay 9, 20238-KMaterial Agreement · Results of OperationsMay 9, 2023DEF 14ADEF 14AMay 8, 20238-KReg FD DisclosureMar 13, 202310-K10-KMar 8, 20238-KResults of OperationsMar 8, 2023SC 13GSC 13GFeb 21, 2023SC 13GSC 13GFeb 15, 20238-KResults of OperationsJan 18, 20238-KMaterial AgreementDec 13, 20228-KMaterial Agreement · New Debt / ObligationDec 8, 202210-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KExecutive Change · Reg FD DisclosureAug 30, 202210-Q10-QAug 2, 20228-KResults of OperationsAug 2, 20228-KShareholder VoteJun 10, 2022SC 13GSC 13GJun 6, 202210-Q10-QMay 10, 20228-KResults of OperationsMay 10, 2022DEFA14ADEFA14AApr 29, 2022DEF 14ADEF 14AApr 29, 20228-KExecutive Change · Reg FD DisclosureMar 4, 202210-K10-KMar 3, 20228-KResults of OperationsMar 3, 2022SC 13GSC 13GFeb 15, 20228-KResults of OperationsJan 26, 2022
Insider Activity
In the 90 days to Mar 20, 2026: 2 sold $889K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Moatazedi DavidSee Remarks | Sell | 13,669 | $4.75 | $65K |
| Mar 20, 2026 | Avelar RuiSee Remarks | Sell | 3,119 | $4.75 | $15K |
| Mar 17, 2026 | Moatazedi DavidSee Remarks | Sell | 116,720 | $4.89 | $571K |
| Mar 17, 2026 | Avelar RuiSee Remarks | Sell | 29,996 | $4.89 | $147K |
| Dec 22, 2025 | Moatazedi DavidSee Remarks | Sell | 10,539 | $7.15 | $75K |
| Dec 22, 2025 | Avelar RuiSee Remarks | Sell | 2,261 | $7.15 | $16K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance